跳至主要内容
临床试验/NCT05060172
NCT05060172已完成不适用

A Cross-sectional, Interventional, Single-arm Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Antepartum Fetal Monitoring

Bloom Technologies2 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2021年6月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
96
试验地点
2
主要终点
Extent of agreement between Bloomlife MFM-Pro and CTG in maternal heart rate

研究概览

简要总结

Bloomlife has developed a wearable system (Bloomlife MFM-Pro) that can allow fetal monitoring to be conveniently performed in healthcare settings under supervision of a healthcare professional.

Bloomlife MFM-Pro is a non-invasive, wireless, external monitoring system used to measure fetal heart rate, maternal heart rate, and uterine activity during antepartum (non-stress) testing on pregnant women with a singleton pregnancy.

The purpose of this study is to validate that the Bloomlife MFM-Pro is equivalent to clinical standard-of-care for routine non-stress test (NST) performed at the hospital.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant woman ≥ 18 years old
  • Gestational age ≥ 32 weeks and 0 days
  • Singleton pregnancy
  • Ability to read and understand Dutch or English
  • Willingness to participate in the study

排除标准

  • Implanted pacemaker or any other implanted electrical device
  • Plurality higher than 1
  • History of allergies to skin adhesives
  • Contraindication to the use of the CTG

结局指标

主要结局

Extent of agreement between Bloomlife MFM-Pro and CTG in maternal heart rate

时间窗: 1 hour

Bland-Altman analysis, based on a 95% limits of agreement

Extent of agreement between Bloomlife MFM-Pro and CTG in fetal heart rate

时间窗: 1 hour

Bland-Altman analysis, based on a 95% limits of agreement

次要结局

未报告次要终点

研究者

发起方
Bloom Technologies
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验